{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:53:01Z","timestamp":1793404381009,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tjpad.2024.100016","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:28:28Z","timestamp":1736504908000},"page":"100016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB\/III trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Stephen","family":"Macfarlane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Grimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Mander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brodtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kurrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Drysdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Mannering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\uff0eEmer","family":"MacSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathy","family":"Munisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterre Malou","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul LJ","family":"Dautzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Oschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Tacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Henri-Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Chertkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ging-Yuek Robin","family":"Hsiung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca M","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jubault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Guizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Chezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher U","family":"Missling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan N","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2024.100016_bib0002","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_sbref0003","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's Dement"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100016_bib0004","article-title":"The broken Alzheimer's disease genome","volume":"4","author":"Gouveia Roque","year":"2024","journal-title":"Cell Genom"},{"issue":"2","key":"10.1016\/j.tjpad.2024.100016_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in Early Alzheimer's Disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alz Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100016_bib0006","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100016_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_bib0008","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_bib0009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.tjpad.2024.100016_bib0010","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the safety and efficacy of crenezumab vs placebo in adults with Early Alzheimer Disease","volume":"79","author":"Ostrowitzki","year":"2022","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100016_bib0011","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat Med"},{"issue":"20","key":"10.1016\/j.tjpad.2024.100016_bib0012","doi-asserted-by":"crossref","first-page":"e2114","DOI":"10.1212\/WNL.0000000000207156","article-title":"Accelerated brain volume loss caused by anti\u2013\u03b2-amyloid drugs","volume":"100","author":"Alves","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tjpad.2024.100016_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.705575","article-title":"Sigmar1\u2019s molecular, cellular, and biological functions in regulating cellular pathophysiology","volume":"12","author":"Aishwarya","year":"2021","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.tjpad.2024.100016_bib0020","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1007\/s12035-021-02524-5","article-title":"Emerging benefits: pathophysiological functions and target drugs of the sigma-1 receptor in neurodegenerative diseases","volume":"58","author":"Wu","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.tjpad.2024.100016_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00314","article-title":"Sigma-1 receptor-modulated neuroinflammation in neurological diseases","volume":"12","author":"Jia","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100016_bib0022","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.3390\/ijms24097767","article-title":"SIGMAR1 confers innate resilience against neurodegeneration","volume":"24","author":"Couly","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100016_bib0015","article-title":"A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study","volume":"6","author":"Hampel","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.tjpad.2024.100016_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172796","article-title":"ANAVEX\u00ae2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome","volume":"187","author":"Kaufmann","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/cells8030211","article-title":"Sigma-1 receptor activation induces autophagy and increases proteostasis capacity in vitro and in vivo","volume":"8","author":"Christ","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100016_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-017-9838-2","article-title":"Sigma-1 receptor agonists induce oxidative stress in mitochondria and enhance complex I activity in physiological condition but protect against pathological oxidative stress","volume":"35","author":"Goguadze","year":"2019","journal-title":"Neurotox Res"},{"issue":"8","key":"10.1016\/j.tjpad.2024.100016_bib0019","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.3390\/ijms22084082","article-title":"Sigma-1 Receptor (S1R) interaction with cholesterol: mechanisms of S1R activation and its role in neurodegenerative diseases","volume":"22","author":"Zhemkov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjpad.2024.100016_bib0023","unstructured":"ClinicalTrials.gov. ANAVEX2-73 for treatment of Early Alzheimer's Disease. 2022. https:\/\/clinicaltrials.gov\/search?id=NCT03790709 (October 18, 2023)."},{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimer's Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100016_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_bib0028","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/01688638408401233","article-title":"Cued recall in Amnesia","volume":"6","author":"Buschke","year":"1984","journal-title":"J Clin Neuropsychol"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100016_bib0029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/arclin\/acu031","article-title":"The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's Disease","volume":"29","author":"Lemos","year":"2014","journal-title":"Arch Clin Neuropsychol"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100016_bib0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100016_bib0031","article-title":"Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the National Alzheimer's Coordinating Center Database","volume":"67","author":"O'Bryant","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tjpad.2024.100016_bib0032","series-title":"Handbook of experimental pharmacology, vol 244","doi-asserted-by":"crossref","DOI":"10.1007\/164_2017_35","article-title":"3D homology model of sigma1 receptor. Evolution of the concept of sigma receptors","author":"Laurini","year":"2017"},{"key":"10.1016\/j.tjpad.2024.100016_bib44","series-title":"Multiple Endpoints in Clinical Trials: Guidance for Industry","year":"2022"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100016_bib0033","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s00330-021-08385-9","article-title":"Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore\u00ae","volume":"32","author":"Cavedo","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.tjpad.2024.100016_bib0034","article-title":"Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects","volume":"33","author":"Tran","year":"2022","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/j.tjpad.2024.100016_bib0035","unstructured":"Ashburner J., Barnes G., Chen C.-.C., Daunizeau J., Flandin G., Friston K., et al. SPM12 manual the FIL Methods Group (and honorary members). 2021. https:\/\/www.fil.ion.ucl.ac.uk\/spm\/."},{"key":"10.1016\/j.tjpad.2024.100016_bib0036","series-title":"Medical image computing and computer-assisted intervention \u2013 miccai 2015","article-title":"U-net: convolutional networks for biomedical image segmentation","author":"Ronneberger","year":"2015"},{"key":"10.1016\/j.tjpad.2024.100016_bib0040","unstructured":"U.S. Food and Drug Administration. Early Alzheimer's disease: developing drugs for treatment guidance for industry. 2024."},{"issue":"4","key":"10.1016\/j.tjpad.2024.100016_bib0038","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100016_bib0041","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of tau hyperphosphorylation and a\u03b2 1-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c31 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tjpad.2024.100016_bib0042","doi-asserted-by":"crossref","unstructured":"Teng E., Li Y., Manser P.T., Pickthorn K., Butcher B.D., Blendstrup M., et al. Cross-sectional and longitudinal assessments of function in prodromal-to-mild Alzheimer's disease: a comparison of the ADCS-ADL and A-IADL-Q scales. Alzheimer's Dement: Diagnosis, Assess Dis Monitor. 2023; 15(2). doi:10.1002\/dad2.12452.","DOI":"10.1002\/dad2.12452"},{"key":"10.1016\/j.tjpad.2024.100016_bib0043","first-page":"105","article-title":"Function and clinical meaningfulness of treatments for mild Alzheimer's disease","volume":"2","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100016_bib0037","doi-asserted-by":"crossref","first-page":"E688","DOI":"10.1212\/WNL.0000000000013211","article-title":"Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer Disease amyloid plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100016_bib0039","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database","volume":"131","author":"Nestor","year":"2008","journal-title":"Brain"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:18:28Z","timestamp":1786018708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724006083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2274580724006083"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100016","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB\/III trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Anavex Life Sciences Corp. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100016"}}